评估延长剂量间隔对青少年mRNA COVID-19疫苗有效性的影响
Tim K Tsang1, Sheena G Sullivan2, Yu Meng1
1The University of Hong Kong.
Research square
|July 1, 2024
概括
延长mRNA COVID-19疫苗剂量之间的间隔可能会在第二剂后略有降低感染风险. 然而,在青少年中,更长的间隔增加了第一剂后感染的风险.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在青少年中延长mRNA COVID-19疫苗剂量间隔旨在降低心肌炎风险.
- 以前对延长间隔的研究主要集中在第二剂后的疫苗有效性 (VE),对整体影响的数据有限.
研究的目的:
- 量化延长与常规mRNACOVID-19疫苗剂量间隔对青少年感染风险的影响.
- 为了评估疫苗的有效性 (VE),考虑剂量内期和第二剂后期.
主要方法:
- 香港 (2022年1月至4月) 使用病例通知和疫苗接种率数据.
- 雇佣的日历时间比例危险模型和匹配方法来估计危险比率 (HR) 和赔率比率 (OR).
主要成果:
- 延长剂量间隔 (≥28天) 显示第二剂后感染风险略有降低 (HR:0.86-0.99; OR:0.85-0.87).
- 服用时间间隔较长的青少年在第一剂后的剂量内期间 (HR:1.66) 经历了明显更高的感染风险.
结论:
- 延长mRNA COVID-19疫苗剂量间隔在减少第二剂后感染方面提供了边际好处,但增加了剂量内感染风险.
- 延长剂量间隔的决策需要平衡心肌炎风险,单剂量保护和更长的剂量间隔的潜在益处.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...


